Navigation Links
Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
Date:2/14/2008

PITTSBURGH, Feb. 14 /PRNewswire-FirstCall/ -- In response to several inquiries, Mylan Inc. (NYSE: MYL) confirmed today that its matrix design Fentanyl Transdermal System (FTS) is not part of the widespread recall being conducted by Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ortho-McNeil reported that all lots of 25 mcg/hr Duragesic(R) CII patches sold by PriCara in the United States and all 25 mcg/hr Fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled as a precaution from wholesalers and pharmacies because they may have a cut along one side of the drug reservoir within the patch. The result is possible release of Fentanyl gel from the gel reservoir into the pouch in which the patch is packaged, exposing patients or caregivers directly to Fentanyl gel.

Unlike all other U.S. marketed Fentanyl patches, Mylan's FTS is a matrix patch, not a reservoir patch, and therefore does not leak.

Mylan Vice Chairman and CEO Robert J. Coury commented: "We have always believed that our Fentanyl Transdermal System is differentiated from all other Fentanyl patches in the U.S. market because of its unique matrix design. This is an important product characteristic that should be recognized and understood when choosing a Fentanyl Transdermal System."

Mylan's FTS was the first generic Class II narcotic transdermal product approved by the U.S. Food and Drug Administration.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matr
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Restores Availability of Generic Levothyroxine in Florida
2. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
3. Mylan Declares Quarterly Preferred Stock Dividend
4. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
5. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
6. Mylan Sets Date of 2008 Annual Meeting
7. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
8. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
9. Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
10. Mylan Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
11. Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Chicago, IL (PRWEB) May 27, 2015 The ... Chicago office is open for business to better serve ... is in the Jefferson Park neighborhood on the Northwest side ... Chicago. Appointments can be arranged by calling the Chicago ... location for the Advanced Fertility Center of Chicago. The ...
(Date:5/26/2015)... May 27, 2015 Bellabeat, a ... for women, today announces the LEAF , ... stress, sleep, activity and ovulation. The LEAF seamlessly ... health tracking technolo- gy, particularly its mechanism for ... provide women with lifestyle data and recommendations through ...
(Date:5/26/2015)... 27, 2015 The world of cosmetic ... ’s quest to remain on the cutting edge of ... the many new additions to plastic surgery and his ... surgical procedures, with emphasis on facelifts and mommy-makeovers all ... very user friendly and easy to navigate. The sites ...
(Date:5/26/2015)... Meadows, Ill. (PRWEB) May 26, 2015 ... cosmetic procedures in 2014, according to survey results released ... With increases in skin cancer treatments and several cosmetic ... years ago but remained steady overall compared to 2013 ... row, skin cancer treatments ranked as the most-performed procedure ...
(Date:5/26/2015)... 2015 Now offering innovative, safe, and ... of Dr. Hedi Belajouza in Tunisia extends ... Perfection to the last detail — meticulous hair placement, ... of the harvested follicle — are all results in ... visible in the artistry and talent of Tunisian hair ...
Breaking Medicine News(10 mins):Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 2Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 3Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 4
... Hospitals need a "civility initiative.",According to a new ... to go,beyond traditional customer service programs and evaluate ... white paper, "Character Counts:,Integrating Civility into the Healthcare ... Modern Healthcare and frequent author and speaker. The,paper ...
... won 1st Place as "Best Website for International ... Awards event in the US capitol. Bumrungrad.com is ... expatriates. The Award organizers said the site ... the information they are interested in, provide an ...
... With President Obama preparing to,present his budget proposal, which ... stimulus initiatives and a renewed call for healthcare reform,the ... data,on how the most comprehensive healthcare fix would create ... , Overall, expanding and upgrading ...
... factor 8 and 9 are first target indicationsHOUSTON, Feb. ... assist device program has additional application in the production ... commercially important therapeutic proteins are liver products and comprise ... H. Kelly, CEO of SCLL. "Albumin, the clotting ...
... , , , , , , , , ... , , , , ... , , ... and director of MUM,s Center for Brain, ,Consciousness and Cognition, discusses this first random assignment study of ,the effects of meditation ...
... Sopherion Therapeutics, LLC, a biopharmaceutical company focused ... has announced the appointment of Dr. Marcel Rozencweig ... Prior to joining Sopherion, Dr. Rozencweig was a ... a member of the Sopherion Protocol Development Team ...
Cached Medicine News:Health News:Where's the Civility in Healthcare? New White Paper from The Beryl Institute Explores Why Character Counts in Healthcare 2Health News:Bumrungrad International Hospital Won 1st Place as "Best Website for International Medical Travel" 2Health News:Stem Cell Innovations' C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics 2Health News:Stem Cell Innovations' C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics 3Health News:Transcendental Meditation buffers students against college stress: Study 2Health News:Transcendental Meditation buffers students against college stress: Study 3Health News:Transcendental Meditation buffers students against college stress: Study 4Health News:Transcendental Meditation buffers students against college stress: Study 5Health News:Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs 2
(Date:5/26/2015)... 2015 Cellular testing for ... the future of technologies for screening cells? Now ... Stay ahead there for data, benefiting your influence. ... R&D, opportunities and revenue forecasts. That ... what,s possible for cell-based assays and ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
(Date:5/26/2015)... NEW YORK , May 26, 2015   ... Flatiron Health today announced a strategic ... electronic health record (EHR), data analytics and decision support ... the companies will build upon their existing respective software ... oncology and data analytics product suite. ...
Breaking Medicine Technology:Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 2Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 3Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 4
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: